Session Details

S048 Hot Topics in Pediatric Dermatology

Mon, Mar 22, 9:00 AM - 12:00 PM
3 CME Available Symposium

DESCRIPTION

This symposium aims to give up to date, in depth information regarding new and emerging trends in pediatric dermatology. The session will cover what is new in the management of inflammatory skin diseases in children such as atopic dermatitis, psoriasis, and vitiligo. It will also delve into recent innovations in the care of patients with genetic skin disorders. Other hot topics addressed will include management of infectious diseases and a practical look at AI in pediatric dermatology.

LEARNING OBJECTIVES

1.

Analyze and discuss emerging trends impacting the care of children with inflammatory skin diseases with respect to diagnosis and treatment

2.

Formulate approaches to management of select genetic diseases with evolving therapeutic options

3.

Recognize changing presentations, pathophysiologic insights and management of infections and other pediatric dermatologic disorders

SCHEDULE

9:00 AM

Introduction

Lawrence F. Eichenfield, MD, FAAD

9:05 AM

What's New in Genodermatoses

Amy S. Paller, MD, FAAD

9:25 AM

Infectious Disease Update

Dawn Eichenfield, PhD, MD, FAAD

9:45 AM

Pediatric and Adolescent Vitiligo

Nanette Blythe Silverberg, MD, FAAD

10:05 AM

Question and Answers

Lawrence F. Eichenfield, MD, FAAD, Dawn Eichenfield, PhD, MD, FAAD, Amy S. Paller, MD, FAAD, Nanette Blythe Silverberg, MD, FAAD

10:20 AM

Atopic Dermatitis: What's New?

Lawrence F. Eichenfield, MD, FAAD

10:45 AM

Pediatric Psoriasis: From Severity Assessment to Systemic Treatment

Kelly M. Cordoro, MD, FAAD

11:05 AM

AI in Pediatric Dermatology: Tech Download!

11:25 AM

Vascular Birthmarks

Ilona J. Frieden, MD, FAAD

11:45 AM

Questions and Answers

Lawrence F. Eichenfield, MD, FAAD, Kelly M. Cordoro, MD, FAAD, Ilona J. Frieden, MD, FAAD

DIRECTOR

Lawrence F. Eichenfield, MD, FAAD

Lawrence F. Eichenfield, MD, FAAD

University of California San Diego and Rady Children's Hospital

SPEAKERS

Dawn Eichenfield, PhD, MD, FAAD

Dawn Eichenfield, PhD, MD, FAAD

University of California, San Diego and Rady Children's Hospital, San Diego

Ilona J. Frieden, MD, FAAD

Ilona J. Frieden, MD, FAAD

UCSF

Amy S. Paller, MD, FAAD

Amy S. Paller, MD, FAAD

Northwestern University

Nanette Blythe Silverberg, MD, FAAD

Nanette Blythe Silverberg, MD, FAAD

DISCLOSURES

Dawn Eichenfield, PhD, MD, FAAD

Abeona Therapeutics – Advisory Board(Fees); Amryt Pharma/ Chiesi Farmaceutici – Advisory Board(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, LP – Speaker(Honoraria); Incyte Corporation – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); NobelPharma – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Palvella Therapeutics – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Fees), Speaker(Honoraria);

Lawrence F. Eichenfield, MD, FAAD

Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);

Ilona J. Frieden, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Palvella Therapeutics – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermatologie – Consultant (1099 relationship)(Honoraria);

Amy S. Paller, MD, FAAD

AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);

Nanette Blythe Silverberg, MD, FAAD

Incyte Corporation – Consultant(Grants/Research Funding); Pelthos Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); regeneron – Speaker(Honoraria);